RIGL - RIGEL PHARMACEUTICALS INC
28.87
-0.650 -2.251%
Share volume: 354,349
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.14%
PREVIOUS CLOSE
CHG
CHG%
$29.52
-0.65
-0.02%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-07-2024 | 08-06-2024 | 11-07-2024 | 03-04-2025 | 05-06-2025 | 08-05-2025 | 11-04-2025 | 03-03-2026 | |
| Total revenue | 29.534 M | 36.841 M | 55.307 M | 57.596 M | 53.333 M | 101.685 M | 69.462 M | 69.802 M | |
| Cost of revenue | 2.025 M | 2.807 M | 8.026 M | 5.789 M | 4.409 M | 4.504 M | 4.753 M | 5.955 M | |
| Gross profit | 27.509 M | 34.034 M | 47.281 M | 51.807 M | 48.924 M | 97.181 M | 64.709 M | 63.847 M | |
| 23.72% | 38.92% | 9.57% | -5.56% | 98.64% | -33.41% | -1.33% | |||
| Operating expenses | 34.475 M | 33.587 M | 33.225 M | 35.152 M | 36.151 M | 36.078 M | 36.289 M | 40.677 M | |
| Selling general and admin | 28.449 M | 28.047 M | 27.043 M | 29.520 M | 27.715 M | 29.257 M | 28.936 M | 29.992 M | |
| Research and development | 6.026 M | 5.540 M | 6.182 M | 5.632 M | 8.436 M | 6.821 M | 7.353 M | 10.685 M | |
| Total expenses | 36.500 M | 33.587 M | 33.225 M | 35.152 M | 36.151 M | 36.078 M | 36.289 M | 40.677 M | |
| -7.98% | -1.08% | 5.80% | 2.84% | -0.20% | 0.58% | 12.09% | |||
| Operating income | -6.966 M | 447.000 K | 14.056 M | 16.655 M | 12.773 M | 61.103 M | 28.420 M | 23.170 M | |
| Ebit | -6.966 M | 447.000 K | 14.056 M | 16.655 M | 12.773 M | 61.103 M | 28.420 M | 23.170 M | |
| Pretax income | -8.247 M | -1.030 M | 12.421 M | 15.222 M | 11.511 M | 59.982 M | 27.620 M | 22.714 M | |
| -87.51% | -1,305.92% | 22.55% | -24.38% | 421.08% | -53.95% | -17.76% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 65.000 K | 369.000 K | -280.000 K | -245.351 M | |
| Net income basic | -8.247 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| 100.00% | |||||||||
| Net income | -8.247 M | -1.030 M | 12.421 M | 14.341 M | 11.446 M | 59.613 M | 27.900 M | 268.065 M | |
| 87.51% | 1,305.92% | 15.46% | -20.19% | 420.82% | -53.20% | 860.81% |